1887

Abstract

Human pegivirus (HPgV; originally called GB virus C/hepatitis G virus) is an RNA virus within the genus of the family that commonly causes persistent infection. Worldwide, ~750 million people are actively infected (viraemic) and an estimated 0.75–1.5 billion people have evidence of prior HPgV infection. No causal association between HPgV and disease has been identified; however, several studies described a beneficial relationship between persistent HPgV infection and survival in individuals infected with human immunodeficiency virus. The beneficial effect appeared to be related to a reduction in host immune activation. HPgV replicates well (mean plasma viral loads typically >1×10 genome copies ml); however, the virus grows poorly and systems to study this virus are limited. Consequently, mechanisms of viral persistence and host immune modulation remain poorly characterized, and the primary permissive cell type(s) has not yet been identified. HPgV RNA is found in liver, spleen, bone marrow and PBMCs, including T- and B-lymphocytes, NK-cells, and monocytes, although the mechanism of cell-to-cell transmission is unclear. HPgV RNA is also present in serum microvesicles with properties of exosomes. These microvesicles are able to transmit viral RNA to PBMCs , resulting in productive infection. This review summarizes existing data on HPgV cellular tropism and the effect of HPgV on immune activation in various PBMCs, and discusses how this may influence viral persistence. We conclude that an increased understanding of HPgV replication and immune modulation may provide insights into persistent RNA viral infection of humans.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000086
2015-07-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/7/1521.html?itemId=/content/journal/jgv/10.1099/vir.0.000086&mimeType=html&fmt=ahah

References

  1. Adams M. J., King A. M. Q., Carstens E. B.. ( 2013; ). Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013). . Arch Virol 158:, 2023–2030. [CrossRef] [PubMed]
    [Google Scholar]
  2. Agnello V., Abel G., Elfahal M., Knight G. B., Zhang Q. X.. ( 1999; ). Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. . Proc Natl Acad Sci U S A 96:, 12766–12771. [CrossRef] [PubMed]
    [Google Scholar]
  3. Ahlenstiel G., Titerence R. H., Koh C., Edlich B., Feld J. J., Rotman Y., Ghany M. G., Hoofnagle J. H., Liang T. J. et al. ( 2010; ). Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. . Gastroenterology 138:, 325–335. [CrossRef] [PubMed]
    [Google Scholar]
  4. Berg T., Müller A. R., Platz K. P., Höhne M., Bechstein W. O., Hopf U., Wiedenmann B., Neuhaus P., Schreier E.. ( 1999; ). Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication. . Hepatology 29:, 245–249. [CrossRef] [PubMed]
    [Google Scholar]
  5. Bhanich Supapol W., Remis R. S., Raboud J., Millson M., Tappero J., Kaul R., Kulkarni P., McConnell M. S., Mock P. A. et al. ( 2009; ). Mother-to-child transmission of GB virus C in a cohort of women coinfected with GB virus C and HIV in Bangkok, Thailand. . J Infect Dis 200:, 227–235. [CrossRef] [PubMed]
    [Google Scholar]
  6. Bhattarai N., Stapleton J. T.. ( 2012; ). GB virus C: the good boy virus?. Trends Microbiol 20:, 124–130. [CrossRef] [PubMed]
    [Google Scholar]
  7. Bhattarai N., Rydze R. T., Chivero E. T., Stapleton J. T.. ( 2012; a). GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy. . J Infect Dis 206:, 1469–1472. [CrossRef] [PubMed]
    [Google Scholar]
  8. Bhattarai N., McLinden J. H., Xiang J. H., Kaufman T. M., Stapleton J. T.. ( 2012; b). GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways. . J Immunol 189:, 2211–2216. [CrossRef] [PubMed]
    [Google Scholar]
  9. Bhattarai N., McLinden J. H., Xiang J. H., Landay A. L., Chivero E. T., Stapleton J. T.. ( 2013; ). GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling. . J Immunol 190:, 6351–6359. [CrossRef] [PubMed]
    [Google Scholar]
  10. Bukong T. N., Momen-Heravi F., Kodys K., Bala S., Szabo G.. ( 2014; ). Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. . PLoS Pathog 10:, e1004424. [CrossRef] [PubMed]
    [Google Scholar]
  11. Burke K. P., Cox A. L.. ( 2010; ). Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence. . Immunol Res 47:, 216–227. [CrossRef] [PubMed]
    [Google Scholar]
  12. Chang C. M., Stapleton J. T., Klinzman D., McLinden J. H., Purdue M. P., Katki H. A., Engels E. A.. ( 2014; ). GBV-C infection and risk of NHL among U.S. adults. . Cancer Res 74:, 5553–5560. [CrossRef] [PubMed]
    [Google Scholar]
  13. Chivero E. T., Bhattarai N., Rydze R. T., Winters M. A., Holodniy M., Stapleton J. T.. ( 2014; ). Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro. . J Gen Virol 95:, 1307–1319. [CrossRef] [PubMed]
    [Google Scholar]
  14. Civardi G., Tanzi E., Ferrari B., Vallisa D., Zanetti A., Cavanna L.. ( 1998; ). High prevalence of anti-HGV/E2 antibodies in HCV-positive patients with non Hodgkin’s lymphoma. . Haematologica 83:, 957–958.[PubMed]
    [Google Scholar]
  15. De Maria A., Fogli M., Mazza S., Basso M., Picciotto A., Costa P., Congia S., Mingari M. C., Moretta L.. ( 2007; ). Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. . Eur J Immunol 37:, 445–455. [CrossRef] [PubMed]
    [Google Scholar]
  16. De Renzo A., Persico E., de Marino F., di Giacomo Russo G., Notaro R., di Grazia C., Picardi M., Santoro L., Torella R. et al. ( 2002; ). High prevalence of hepatitis G virus infection in Hodgkin’s disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection. . Haematologica 87:, 714–718.[PubMed]
    [Google Scholar]
  17. Deinhardt F., Holmes A. W., Capps R. B., Popper H.. ( 1967; ). Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. . J Exp Med 125:, 673–688. [CrossRef] [PubMed]
    [Google Scholar]
  18. Dreux M., Garaigorta U., Boyd B., Décembre E., Chung J., Whitten-Bauer C., Wieland S., Chisari F. V.. ( 2012; ). Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. . Cell Host Microbe 12:, 558–570. [CrossRef] [PubMed]
    [Google Scholar]
  19. Durie F. H., Foy T. M., Masters S. R., Laman J. D., Noelle R. J.. ( 1994; ). The role of CD40 in the regulation of humoral and cell-mediated immunity. . Immunol Today 15:, 406–411. [CrossRef] [PubMed]
    [Google Scholar]
  20. Elkayam O., Hassoba H. M., Ferrell L. D., Garcia-Kennedy R., Gish R. G., Wright T. L., Laffler T., Traylor D., Hunt G., Rosenthal P.. ( 1999; ). GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplant. . Pediatr Res 45:, 795–798. [CrossRef] [PubMed]
    [Google Scholar]
  21. Ellenrieder V., Weidenbach H., Frickhofen N., Michel D., Prümmer O., Klatt S., Bernas O., Mertens T., Adler G., Beckh K.. ( 1998; ). HCV and HGV in B-cell non-Hodgkin’s lymphoma. . J Hepatol 28:, 34–39. [CrossRef] [PubMed]
    [Google Scholar]
  22. Evans M. J., von Hahn T., Tscherne D. M., Syder A. J., Panis M., Wölk B., Hatziioannou T., McKeating J. A., Bieniasz P. D., Rice C. M.. ( 2007; ). Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. . Nature 446:, 801–805. [CrossRef] [PubMed]
    [Google Scholar]
  23. Fan X., Xu Y., Solomon H., Ramrakhiani S., Neuschwander-Tetri B. A., Di Bisceglie A. M.. ( 1999; ). Is hepatitis G/GB virus-C virus hepatotropic? Detection of hepatitis G/GB virus-C viral RNA in liver and serum. . J Med Virol 58:, 160–164. [CrossRef] [PubMed]
    [Google Scholar]
  24. Feng Z., Hensley L., McKnight K. L., Hu F., Madden V., Ping L., Jeong S. H., Walker C., Lanford R. E., Lemon S. M.. ( 2013; ). A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. . Nature 496:, 367–371. [CrossRef] [PubMed]
    [Google Scholar]
  25. Fernández L., Bleda M. J., Gómara M. J., Haro I.. ( 2013; ). Design and application of GB virus C (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection. . Anal Bioanal Chem 405:, 3973–3982. [CrossRef] [PubMed]
    [Google Scholar]
  26. Fogeda M., Navas S., Martín J., Casqueiro M., Rodríguez E., Arocena C., Carreño V.. ( 1999; ). In vitro infection of human peripheral blood mononuclear cells by GB virus C/hepatitis G virus. . J Virol 73:, 4052–4061.[PubMed]
    [Google Scholar]
  27. Foy T. M., Durie F. H., Noelle R. J.. ( 1994; ). The expansive role of CD40 and its ligand, gp39, in immunity. . Semin Immunol 6:, 259–266. [CrossRef] [PubMed]
    [Google Scholar]
  28. George S. L., Xiang J. H., Stapleton J. T.. ( 2003; ). Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. . Virology 316:, 191–201. [CrossRef] [PubMed]
    [Google Scholar]
  29. George S. L., Varmaz D., Stapleton J. T.. ( 2006; ). GB virus C replicates in primary T and B lymphocytes. . J Infect Dis 193:, 451–454. [CrossRef] [PubMed]
    [Google Scholar]
  30. Giannoulis E., Economopoulos T., Mandraveli K., Giannoulis K., Nikolaides C., Zervou E., Papageorgiou E., Zoulas D., Tourkantonis A. et al. ( 2004; ). The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study. . Acta Haematol 112:, 189–193. [CrossRef] [PubMed]
    [Google Scholar]
  31. Gómara M. J., Fernández L., Pérez T., Tenckhoff S., Casanovas A., Tillmann H. L., Haro I.. ( 2011; ). Diagnostic value of anti-GBV-C antibodies in HIV-infected patients. . Chem Biol Drug Des 78:, 277–282. [CrossRef] [PubMed]
    [Google Scholar]
  32. Grakoui A., Shoukry N. H., Woollard D. J., Han J. H., Hanson H. L., Ghrayeb J., Murthy K. K., Rice C. M., Walker C. M.. ( 2003; ). HCV persistence and immune evasion in the absence of memory T cell help. . Science 302:, 659–662. [CrossRef] [PubMed]
    [Google Scholar]
  33. Gutierrez R. A., Dawson G. J., Knigge M. F., Melvin S. L., Heynen C. A., Kyrk C. R., Young C. E., Carrick R. J., Schlauder G. G. et al. ( 1997; ). Seroprevalence of GB virus C and persistence of RNA and antibody. . J Med Virol 53:, 167–173. [CrossRef] [PubMed]
    [Google Scholar]
  34. Heringlake S., Ockenga J., Tillmann H. L., Trautwein C., Meissner D., Stoll M., Hunt J., Jou C., Solomon N. et al. ( 1998; ). GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?. J Infect Dis 177:, 1723–1726. [CrossRef] [PubMed]
    [Google Scholar]
  35. Hino K., Moriya T., Ohno N., Takahashi K., Hoshino H., Ishiyama N., Katayama K., Yoshizawa H., Mishiro S.. ( 1998; ). Mother-to-infant transmission occurs more frequently with GB virus C than hepatitis C virus. . Arch Virol 143:, 65–72. [CrossRef] [PubMed]
    [Google Scholar]
  36. Hunt P. W., Martin J. N., Sinclair E., Bredt B., Hagos E., Lampiris H., Deeks S. G.. ( 2003; ). T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. . J Infect Dis 187:, 1534–1543. [CrossRef] [PubMed]
    [Google Scholar]
  37. Kapoor A., Simmonds P., Scheel T. K., Hjelle B., Cullen J. M., Burbelo P. D., Chauhan L. V., Duraisamy R., Sanchez Leon M. et al. ( 2013; ). Identification of rodent homologs of hepatitis C virus and pegiviruses. . MBio 4:, e00216-13. [CrossRef] [PubMed]
    [Google Scholar]
  38. Keck Z. Y., Li S. H., Xia J., von Hahn T., Balfe P., McKeating J. A., Witteveldt J., Patel A. H., Alter H. et al. ( 2009; ). Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity. . J Virol 83:, 6149–6160. [CrossRef] [PubMed]
    [Google Scholar]
  39. Keck Z. Y., Angus A. G., Wang W., Lau P., Wang Y., Gatherer D., Patel A. H., Foung S. K.. ( 2014; ). Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412–423. . PLoS Pathog 10:, e1004297. [CrossRef] [PubMed]
    [Google Scholar]
  40. Keresztes K., Takács M., Horányi M., Miltényi Z., Illés A.. ( 2003; ). HCV and HGV infection in Hodgkin’s disease. . Pathol Oncol Res 9:, 222–225. [CrossRef] [PubMed]
    [Google Scholar]
  41. Kirwan S., Merriam D., Barsby N., McKinnon A., Burshtyn D. N.. ( 2006; ). Vaccinia virus modulation of natural killer cell function by direct infection. . Virology 347:, 75–87. [CrossRef] [PubMed]
    [Google Scholar]
  42. Kisiel E., Cortez K. C., Pawełczyk A., Ośko I. B., Kubisa N., Laskus T., Radkowski M.. ( 2013; ). Hepatitis G virus/GBV-C in serum, peripheral blood mononuclear cells and bone marrow in patients with hematological malignancies. . Infect Genet Evol 19:, 195–199. [CrossRef] [PubMed]
    [Google Scholar]
  43. Kleinman S.. ( 2001; ). Hepatitis G virus biology, epidemiology, and clinical manifestations: implications for blood safety. . Transfus Med Rev 15:, 201–212. [CrossRef] [PubMed]
    [Google Scholar]
  44. Krajden M., Yu A., Braybrook H., Lai A. S., Mak A., Chow R., Cook D., Tellier R., Petric M. et al. ( 2010; ). GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study. . Int J Cancer 126:, 2885–2892.[PubMed]
    [Google Scholar]
  45. Laras A., Zacharakis G., Hadziyannis S. J.. ( 1999; ). Absence of the negative strand of GBV-C/HGV RNA from the liver. . J Hepatol 30:, 383–388. [CrossRef] [PubMed]
    [Google Scholar]
  46. Laskus T., Radkowski M., Wang L. F., Vargas H., Rakela J.. ( 1997; ). Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. . J Virol 71:, 7804–7806.[PubMed]
    [Google Scholar]
  47. Lauck M., Bailey A. L., Anderson K. G., Goldberg T. L., Sabeti P. C., O’Connor D. H.. ( 2015; ). GB virus C coinfections in West African Ebola patients. . J Virol 89:, 2425–2429. [CrossRef] [PubMed]
    [Google Scholar]
  48. Leary T. P., Muerhoff S., Simons J. N., Pilot-Matias T. J., Erker J. C., Chalmers M. L., Schlauder G. G., Dawson G. J., Desai S. M., Mushahwar I. K.. ( 1996; ). Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. . J Med Virol 48:, 60–67. [CrossRef] [PubMed]
    [Google Scholar]
  49. Lemon S. M.. ( 2010; ). Induction and evasion of innate antiviral responses by hepatitis C virus. . J Biol Chem 285:, 22741–22747. [CrossRef] [PubMed]
    [Google Scholar]
  50. Lin H. H., Kao J. H., Yeh K. Y., Liu D. P., Chang M. H., Chen P. J., Chen D. S.. ( 1998; ). Mother-to-infant transmission of GB virus C/hepatitis G virus: the role of high-titered maternal viremia and mode of delivery. . J Infect Dis 177:, 1202–1206. [CrossRef] [PubMed]
    [Google Scholar]
  51. Loureiro C. L., Alonso R., Pacheco B. A., Uzcátegui M. G., Villegas L., León G., De Saéz A., Liprandi F., López J. L., Pujol F. H.. ( 2002; ). High prevalence of GB virus C/hepatitis G virus genotype 3 among autochthonous Venezuelan populations. . J Med Virol 68:, 357–362. [CrossRef] [PubMed]
    [Google Scholar]
  52. Lozach, P. Y., Lortat-Jacob, H., de Lacroix de Lavalette, A., Staropoli, I., Foung, S., Amara, A., Houles, C., Fieschi, F., Schwartz, O. & other authors (2003). DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278 , 20358–20366.
  53. Maggi F., Fornai C., Zaccaro L., Morrica A., Vatteroni M. L., Isola P., Marchi S., Ricchiuti A., Pistello M., Bendinelli M.. ( 2001; ). TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. . J Med Virol 64:, 190–194. [CrossRef] [PubMed]
    [Google Scholar]
  54. Maidana-Giret M. T., Silva T. M., Sauer M. M., Tomiyama H., Levi J. E., Bassichetto K. C., Nishiya A., Diaz R. S., Sabino E. C. et al. ( 2009; ). GB virus type C infection modulates T-cell activation independently of HIV-1 viral load. . AIDS 23:, 2277–2287. [CrossRef] [PubMed]
    [Google Scholar]
  55. Martin, D. N. & Uprichard, S. L. (2013). Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci U S A 110 , 10777–10782.
  56. Meckes D. G. Jr, Raab-Traub N.. ( 2011; ). Microvesicles and viral infection. . J Virol 85:, 12844–12854. [CrossRef] [PubMed]
    [Google Scholar]
  57. Mellor J., Haydon G., Blair C., Livingstone W., Simmonds P.. ( 1998; ). Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. . J Gen Virol 79:, 705–714.[PubMed]
    [Google Scholar]
  58. Michaelis S., Kazakov D. V., Schmid M., Dummer R., Burg G., Kempf W.. ( 2003; ). Hepatitis C and G viruses in B-cell lymphomas of the skin. . J Cutan Pathol 30:, 369–372. [CrossRef] [PubMed]
    [Google Scholar]
  59. Milush J. M., Mir K. D., Sundaravaradan V., Gordon S. N., Engram J., Cano C. A., Reeves J. D., Anton E., O’Neill E. et al. ( 2011; ). Lack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cells. . J Clin Invest 121:, 1102–1110. [CrossRef] [PubMed]
    [Google Scholar]
  60. Mohr E. L., Stapleton J. T.. ( 2009; ). GB virus type C interactions with HIV: the role of envelope glycoproteins. . J Viral Hepat 16:, 757–768. [CrossRef] [PubMed]
    [Google Scholar]
  61. Moradpour D., Penin F., Rice C. M.. ( 2007; ). Replication of hepatitis C virus. . Nat Rev Microbiol 5:, 453–463. [CrossRef] [PubMed]
    [Google Scholar]
  62. Nakamura S., Takagi T., Matsuda T.. ( 1997; ). Hepatitis G virus RNA in patients with B-cell non-Hodgkin’s lymphoma. . Br J Haematol 98:, 1051–1052.[PubMed]
    [Google Scholar]
  63. Nattermann J., Nischalke H. D., Kupfer B., Rockstroh J., Hess L., Sauerbruch T., Spengler U.. ( 2003; ). Regulation of CC chemokine receptor 5 in hepatitis G virus infection. . AIDS 17:, 1457–1462. [CrossRef] [PubMed]
    [Google Scholar]
  64. Nunnari G., Nigro L., Palermo F., Attanasio M., Berger A., Doerr H. W., Pomerantz R. J., Cacopardo B.. ( 2003; ). Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. . Ann Intern Med 139:, 26–30. [CrossRef] [PubMed]
    [Google Scholar]
  65. Ohto H., Ujiie N., Sato A., Okamoto H., Mayumi M..Vertical Transmission of Hepatitis Viruses Collaborative Study Group ( 2000; ). Mother-to-infant transmission of GB virus type C/HGV. . Transfusion 40:, 725–730. [CrossRef] [PubMed]
    [Google Scholar]
  66. Okamoto H.. ( 2009; ). History of discoveries and pathogenicity of TT viruses. . Curr Top Microbiol Immunol 331:, 1–20.[PubMed]
    [Google Scholar]
  67. Oliviero B., Varchetta S., Paudice E., Michelone G., Zaramella M., Mavilio D., De Filippi F., Bruno S., Mondelli M. U.. ( 2009; ). Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. . Gastroenterology 137:, 1151–1160. [CrossRef] [PubMed]
    [Google Scholar]
  68. Pavesi A.. ( 2001; ). Origin and evolution of GBV-C/hepatitis G virus and relationships with ancient human migrations. . J Mol Evol 53:, 104–113. [CrossRef] [PubMed]
    [Google Scholar]
  69. Peppa D., Micco L., Javaid A., Kennedy P. T. F., Schurich A., Dunn C., Pallant C., Ellis G., Khanna P. et al. ( 2010; ). Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. . PLoS Pathog 6:, e1001227. [CrossRef] [PubMed]
    [Google Scholar]
  70. Pessoa M. G., Terrault N. A., Detmer J., Kolberg J., Collins M., Hassoba H. M., Wright T. L.. ( 1998; ). Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. . Hepatology 27:, 877–880. [CrossRef] [PubMed]
    [Google Scholar]
  71. Petitjean G., Chevalier M. F., Tibaoui F., Didier C., Manea M. E., Liovat A. S., Campa P., Müller-Trutwin M., Girard P. M. et al. ( 2012; ). Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection. . AIDS 26:, 139–148. [CrossRef] [PubMed]
    [Google Scholar]
  72. Ploss A., Evans M. J., Gaysinskaya V. A., Panis M., You H., de Jong Y. P., Rice C. M.. ( 2009; ). Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. . Nature 457:, 882–886. [CrossRef] [PubMed]
    [Google Scholar]
  73. Radkowski M., Kubicka J., Kisiel E., Cianciara J., Nowicki M., Rakela J., Laskus T.. ( 2000; ). Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. . Blood 95:, 3986–3989.[PubMed]
    [Google Scholar]
  74. Rajagopalan S., Long E. O.. ( 2000; ). Use of vaccinia virus for functional gene transfer in natural killer cells. . Methods Mol Biol 121:, 265–272.[PubMed]
    [Google Scholar]
  75. Ramakrishnaiah V., Thumann C., Fofana I., Habersetzer F., Pan Q. W., de Ruiter P. E., Willemsen R., Demmers J. A. A., Stalin Raj V. et al. ( 2013; ). Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. . Proc Natl Acad Sci U S A 110:, 13109–13113. [CrossRef] [PubMed]
    [Google Scholar]
  76. Rehermann B.. ( 2013; ). Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. . Nat Med 19:, 859–868. [CrossRef] [PubMed]
    [Google Scholar]
  77. Ruiz V., Giordano M., Rivero C. W., Minassian M. L., Cuestas M. L., Trinks J., Mathet V. L., Oubiña J. R.. ( 2010; ). GB virus C quasispecies detected in plasma and lymphocyte subsets in a natural human infection. . J Gen Virol 91:, 1687–1692. [CrossRef] [PubMed]
    [Google Scholar]
  78. Rydze R. T., Bhattarai N., Stapleton J. T.. ( 2012; ). GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death. . Antivir Ther 17:, 1271–1279. [CrossRef] [PubMed]
    [Google Scholar]
  79. Sainz B. Jr, Barretto N., Martin D. N., Hiraga N., Imamura M., Hussain S., Marsh K. A., Yu X., Chayama K. et al. ( 2012; ). Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. . Nat Med 18:, 281–285. [CrossRef] [PubMed]
    [Google Scholar]
  80. Sánchez-Puig J. M., Sánchez L., Roy G., Blasco R.. ( 2004; ). Susceptibility of different leukocyte cell types to Vaccinia virus infection. . Virol J 1:, 10. [CrossRef] [PubMed]
    [Google Scholar]
  81. Schwarze-Zander C., Blackard J. T., Zheng H., Addo M. M., Lin W., Robbins G. K., Sherman K. E., Zdunek D., Hess G. et al. ( 2006; ). GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. . J Infect Dis 194:, 410–419. [CrossRef] [PubMed]
    [Google Scholar]
  82. Schwarze-Zander C., Neibecker M., Othman S., Welzel C., Schulz M., Voigt E., Vogel M., Wasmuth C., Luechters G. et al. ( 2007; ). GBV-C co-infection in HIV patients is associated with low CCR5 and CXCR4 surface expression on CD4 cells. . Hepatology 46: (Suppl. S1), 891A.
    [Google Scholar]
  83. Sharp P. M., Simmonds P.. ( 2011; ). Evaluating the evidence for virus/host co-evolution. . Curr Opin Virol 1:, 436–441. [CrossRef] [PubMed]
    [Google Scholar]
  84. Sibley S. D., Lauck M., Bailey A. L., Hyeroba D., Tumukunde A., Weny G., Chapman C. A., O’Connor D. H., Goldberg T. L., Friedrich T. C.. ( 2014; ). Discovery and characterization of distinct simian pegiviruses in three wild African Old World monkey species. . PLoS One 9:, e98569. [CrossRef] [PubMed]
    [Google Scholar]
  85. Simmonds P., Smith D. B.. ( 1999; ). Structural constraints on RNA virus evolution. . J Virol 73:, 5787–5794.[PubMed]
    [Google Scholar]
  86. Simons J. N., Leary T. P., Dawson G. J., Pilot-Matias T. J., Muerhoff A. S., Schlauder G. G., Desai S. M., Mushahwar I. K.. ( 1995; ). Isolation of novel virus-like sequences associated with human hepatitis. . Nat Med 1:, 564–569. [CrossRef] [PubMed]
    [Google Scholar]
  87. Stapleton J. T.. ( 2003; ). GB virus type C/hepatitis G virus. . Semin Liver Dis 23:, 137–148. [CrossRef] [PubMed]
    [Google Scholar]
  88. Stapleton J. T., Chaloner K., Zhang J. Y., Klinzman D., Souza I. E., Xiang J. H., Landay A., Fahey J., Pollard R., Mitsuyasu R.. ( 2009; ). GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. . AIDS 23:, 605–610. [CrossRef] [PubMed]
    [Google Scholar]
  89. Stapleton J. T., Foung S., Muerhoff A. S., Bukh J., Simmonds P.. ( 2011; ). The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. . J Gen Virol 92:, 233–246. [CrossRef] [PubMed]
    [Google Scholar]
  90. Stapleton J. T., Bukh J., Muerhoff, A. S., Foung S., Simmonds P. . ( 2012; a). Assignment of human, simian and bat pegiviruses (previously described as GBV-A, GBV-C, and GBV-D) as members of a new genus (Pegivirus) within the Flaviviridae. http://www.ictvonline.org/proposals/2012.011a-dV.A.v2.Pegivirus.pdf
  91. Stapleton J. T., Chaloner K., Martenson J. A., Zhang J. Y., Klinzman D., Xiang J. H., Sauter W., Desai S. N., Landay A.. ( 2012; b). GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals. . PLoS One 7:, e50563. [CrossRef] [PubMed]
    [Google Scholar]
  92. Stapleton J. T., Martinson J. A., Klinzman D., Xiang J., Desai S. N., Landay A.. ( 2013; ). GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals. . AIDS 27:, 1829–1832. [CrossRef] [PubMed]
    [Google Scholar]
  93. Stapleton J. T., Xiang J., McLinden J. H., Bhattarai N., Chivero E. T., Klinzman D., Kaufman T. M., Chang Q.. ( 2014; ). A novel T cell evasion mechanism in persistent RNA virus infection. . Trans Am Clin Climatol Assoc 125:, 14–24.[PubMed]
    [Google Scholar]
  94. Sundaravaradan V., Mir K. D., Sodora D. L.. ( 2012; ). Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup. . Curr Opin HIV AIDS 7:, 164–171. [CrossRef] [PubMed]
    [Google Scholar]
  95. Sundaravaradan V., Saleem R., Micci L., Gasper M. A., Ortiz A. M., Else J., Silvestri G., Paiardini M., Aitchison J. D., Sodora D. L.. ( 2013; ). Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection. . PLoS Pathog 9:, e1003441. [CrossRef] [PubMed]
    [Google Scholar]
  96. Tacke M., Schmolke S., Schlueter V., Sauleda S., Esteban J. I., Tanaka E., Kiyosawa K., Alter H. J., Schmitt U. et al. ( 1997; ). Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. . Hepatology 26:, 1626–1633. [CrossRef] [PubMed]
    [Google Scholar]
  97. Takahashi M., Asabe S., Gotanda Y., Kishimoto J., Tsuda F., Okamoto H.. ( 2002; ). TT virus is distributed in various leukocyte subpopulations at distinct levels, with the highest viral load in granulocytes. . Biochem Biophys Res Commun 290:, 242–248. [CrossRef] [PubMed]
    [Google Scholar]
  98. Tan D., Matsumoto A., Conry-Cantilena C., Melpolder J. C., Shih J. W. K., Leuther M., Hess G., Gibble J. W., Ness P. M., Alter H. J.. ( 1999; ). Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. . J Infect Dis 179:, 1055–1061. [CrossRef] [PubMed]
    [Google Scholar]
  99. Tanaka E., Kiyosawa K., Shimoda K., Hino K., Tacke M., Schmolke S., Engel A. M., Hess G.. ( 1998; a). Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis. . J Viral Hepat 5:, 153–159. [CrossRef] [PubMed]
    [Google Scholar]
  100. Tanaka Y., Mizokami M., Orito E., Ohba K., Nakano T., Kato T., Kondo Y., Ding X., Ueda R. et al. ( 1998; b). GB virus C/hepatitis G virus infection among Colombian native Indians. . Am J Trop Med Hyg 59:, 462–467.[PubMed]
    [Google Scholar]
  101. Thomas D. L., Nakatsuji Y., Shih J. W., Alter H. J., Nelson K. E., Astemborski J. A., Lyles C. M., Vlahov D.. ( 1997; ). Persistence and clinical significance of hepatitis G virus infections in injecting drug users. . J Infect Dis 176:, 586–592. [CrossRef] [PubMed]
    [Google Scholar]
  102. Thomas D. L., Vlahov D., Alter H. J., Hunt J. C., Marshall R., Astemborski J., Nelson K. E.. ( 1998; ). Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. . J Infect Dis 177:, 539–542. [CrossRef] [PubMed]
    [Google Scholar]
  103. Tillmann H. L., Heringlake S., Trautwein C., Meissner D., Nashan B., Schlitt H. J., Kratochvil J., Hunt J., Qiu X. et al. ( 1998; ). Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. . Hepatology 28:, 379–384. [CrossRef] [PubMed]
    [Google Scholar]
  104. Tillmann H. L., Heiken H., Knapik-Botor A., Heringlake S., Ockenga J., Wilber J. C., Goergen B., Detmer J., McMorrow M. et al. ( 2001; ). Infection with GB virus C and reduced mortality among HIV-infected patients. . N Engl J Med 345:, 715–724. [CrossRef] [PubMed]
    [Google Scholar]
  105. Toyoda H., Fukuda Y., Hayakawa T., Takamatsu J., Saito H.. ( 1998; ). Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. . J Acquir Immune Defic Syndr Hum Retrovirol 17:, 209–213. [CrossRef] [PubMed]
    [Google Scholar]
  106. Tucker T. J., Smuts H. E. M., Eedes C., Knobel G. D., Eickhaus P., Robson S. C., Kirsch R. E.. ( 2000; ). Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. . J Med Virol 61:, 52–58. [CrossRef] [PubMed]
    [Google Scholar]
  107. Vahidnia F., Petersen M., Stapleton J. T., Rutherford G. W., Busch M., Custer B.. ( 2012; ). Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease. . Clin Infect Dis 55:, 1012–1019. [CrossRef] [PubMed]
    [Google Scholar]
  108. Welsh R. M., Waggoner S. N.. ( 2013; ). NK cells controlling virus-specific T cells: rheostats for acute vs. persistent infections. . Virology 435:, 37–45. [CrossRef] [PubMed]
    [Google Scholar]
  109. Williams C. F., Klinzman D., Yamashita T. E., Xiang J., Polgreen P. M., Rinaldo C., Liu C., Phair J., Margolick J. B. et al. ( 2004; ). Persistent GB virus C infection and survival in HIV-infected men. . N Engl J Med 350:, 981–990. [CrossRef] [PubMed]
    [Google Scholar]
  110. Wünschmann S., Medh J. D., Klinzmann D., Schmidt W. N., Stapleton J. T.. ( 2000; ). Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. . J Virol 74:, 10055–10062. [CrossRef] [PubMed]
    [Google Scholar]
  111. Wünschmann S., Muller H. M., Stipp C. S., Hemler M. E., Stapleton J. T.. ( 2006; ). In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs. . J Infect Dis 194:, 1058–1067. [CrossRef] [PubMed]
    [Google Scholar]
  112. Xiang J. H., Klinzman D., McLinden J., Schmidt W. N., LaBrecque D. R., Gish R., Stapleton J. T.. ( 1998; ). Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. . J Virol 72:, 2738–2744.[PubMed]
    [Google Scholar]
  113. Xiang J., Wünschmann S., Schmidt W., Shao J., Stapleton J. T.. ( 2000; ). Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. . J Virol 74:, 9125–9133. [CrossRef] [PubMed]
    [Google Scholar]
  114. Xiang J. H., Wünschmann S., Diekema D. J., Klinzman D., Patrick K. D., George S. L., Stapleton J. T.. ( 2001; ). Effect of coinfection with GB virus C on survival among patients with HIV infection. . N Engl J Med 345:, 707–714. [CrossRef] [PubMed]
    [Google Scholar]
  115. Xiang J. H., George S. L., Wünschmann S., Chang Q., Klinzman D., Stapleton J. T.. ( 2004; ). Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. . Lancet 363:, 2040–2046. [CrossRef] [PubMed]
    [Google Scholar]
  116. Zeisel M. B., Felmlee D. J., Baumert T. F.. ( 2013; ). Hepatitis C virus entry. . Curr Top Microbiol Immunol 369:, 87–112. [CrossRef] [PubMed]
    [Google Scholar]
  117. Zhang W., Chaloner K., Tillmann H. L., Williams C. F., Stapleton J. T.. ( 2006; ). Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. . HIV Med 7:, 173–180. [CrossRef] [PubMed]
    [Google Scholar]
  118. Zhong S., Yeo W., Tang M., Liu C. L., Lin X. R., Ho W. M., Hui P., Johnson P. J.. ( 2002; ). Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients. . J Med Virol 66:, 428–434. [CrossRef] [PubMed]
    [Google Scholar]
  119. Zhu T., Korber B. T., Nahmias A. J., Hooper E., Sharp P. M., Ho D. D.. ( 1998; ). An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. . Nature 391:, 594–597. [CrossRef] [PubMed]
    [Google Scholar]
  120. Zona L., Tawar R. G., Zeisel M. B., Xiao F., Schuster C., Lupberger J., Baumert T. F.. ( 2014; ). CD81-receptor associations – impact for hepatitis C virus entry and antiviral therapies. . Viruses 6:, 875–892. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000086
Loading
/content/journal/jgv/10.1099/vir.0.000086
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error